Search research articles
Contact Us
Filters
Showing results (161-170 of 225) with videos related to
Page
of 23
Sort By:
Academic Radiology
|
January 1, 1995
Intravenous manganese-mesoporphyrin as a magnetic resonance imaging contrast agent: an experimental model using VX-2 carcinoma in rabbits
D H Robinson, U P Schmiedl, F L Starr, et al.
Immunogenetics
|
January 1, 1989
Expression of Ly-6A/E alloantigens in thymocyte and T-lymphocyte subsets: variability related to the Ly-6a and Ly-6b haplotypes
E K Codias, C Cray, R D Baler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 25, 2016
Developmental Progression and Interrelationship of Central and Effector Regulatory T Cell Subsets
Kevin H Toomer, Xiaomei Yuan, Jing Yang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 1, 1995
Biochemical identity and characterization of the mouse interleukin-2 receptor beta and gamma c subunits
T R Malek, R K Furse, M L Fleming, et al.
Neurology
|
November 26, 2003
Endovascular embolectomy of acute basilar artery occlusion
W Yu, D Binder, A Foster-Barber, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1986
Antigen-specific murine T cell clones produce soluble interleukin 2 receptor on stimulation with specific antigens
D K Wagner, J York-Jolley, T R Malek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 13, 2012
IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells
Guoyan Cheng, Xiaomei Yuan, Matthew S Tsai, et al.
The Journal of Experimental Medicine
|
August 1, 1985
Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self
T Mizuochi, H Golding, A S Rosenberg, et al.
Diabetes
|
January 11, 2015
Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes
Aixin Yu, Isaac Snowhite, Francesco Vendrame, et al.
Blood
|
April 2, 2014
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice
Robert G Newman, Michael J Dee, Thomas R Malek, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 225) with videos related to
Sort By:
Page
of 23
Academic Radiology
|
January 1, 1995
Intravenous manganese-mesoporphyrin as a magnetic resonance imaging contrast agent: an experimental model using VX-2 carcinoma in rabbits
D H Robinson, U P Schmiedl, F L Starr, et al.
Immunogenetics
|
January 1, 1989
Expression of Ly-6A/E alloantigens in thymocyte and T-lymphocyte subsets: variability related to the Ly-6a and Ly-6b haplotypes
E K Codias, C Cray, R D Baler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 25, 2016
Developmental Progression and Interrelationship of Central and Effector Regulatory T Cell Subsets
Kevin H Toomer, Xiaomei Yuan, Jing Yang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 1, 1995
Biochemical identity and characterization of the mouse interleukin-2 receptor beta and gamma c subunits
T R Malek, R K Furse, M L Fleming, et al.
Neurology
|
November 26, 2003
Endovascular embolectomy of acute basilar artery occlusion
W Yu, D Binder, A Foster-Barber, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1986
Antigen-specific murine T cell clones produce soluble interleukin 2 receptor on stimulation with specific antigens
D K Wagner, J York-Jolley, T R Malek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 13, 2012
IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells
Guoyan Cheng, Xiaomei Yuan, Matthew S Tsai, et al.
The Journal of Experimental Medicine
|
August 1, 1985
Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self
T Mizuochi, H Golding, A S Rosenberg, et al.
Diabetes
|
January 11, 2015
Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes
Aixin Yu, Isaac Snowhite, Francesco Vendrame, et al.
Blood
|
April 2, 2014
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice
Robert G Newman, Michael J Dee, Thomas R Malek, et al.
Page
of 23